- Home
- COEP vs ICMB Comparison
COEP vs ICMB Comparison
Compare COEP & ICMB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- COEP
- ICMB
- Stock Information
- Founded
- COEP 2017
- ICMB 2012
- Country
- COEP United States
- ICMB United States
- Employees
- COEP N/A
- ICMB N/A
- Industry
- COEP Biotechnology: Biological Products (No Diagnostic Substances)
- ICMB Finance: Consumer Services
- Sector
- COEP Health Care
- ICMB Finance
- Exchange
- COEP Nasdaq
- ICMB Nasdaq
- Market Cap
- COEP 39.0M
- ICMB 41.1M
- IPO Year
- COEP N/A
- ICMB N/A
- Fundamental
- Price
- COEP $9.31
- ICMB $2.80
- Analyst Decision
- COEP
- ICMB
- Analyst Count
- COEP 0
- ICMB 0
- Target Price
- COEP N/A
- ICMB N/A
- AVG Volume (30 Days)
- COEP 107.6K
- ICMB 56.5K
- Earning Date
- COEP 05-27-2025
- ICMB 05-13-2025
- Dividend Yield
- COEP N/A
- ICMB 17.12%
- EPS Growth
- COEP N/A
- ICMB N/A
- EPS
- COEP N/A
- ICMB N/A
- Revenue
- COEP N/A
- ICMB $21,628,977.00
- Revenue This Year
- COEP N/A
- ICMB N/A
- Revenue Next Year
- COEP N/A
- ICMB N/A
- P/E Ratio
- COEP N/A
- ICMB N/A
- Revenue Growth
- COEP N/A
- ICMB N/A
- 52 Week Low
- COEP $2.31
- ICMB $2.46
- 52 Week High
- COEP $13.70
- ICMB $3.67
- Technical
- Relative Strength Index (RSI)
- COEP 49.50
- ICMB 45.17
- Support Level
- COEP $7.81
- ICMB $2.75
- Resistance Level
- COEP $10.86
- ICMB $3.01
- Average True Range (ATR)
- COEP 1.45
- ICMB 0.10
- MACD
- COEP 0.09
- ICMB 0.01
- Stochastic Oscillator
- COEP 62.07
- ICMB 33.23
About COEP Coeptis Therapeutics Holdings Inc.
Coeptis Therapeutics Holdings Inc is a biopharmaceutical company developing cell therapy platforms for patients with cancer. The company's product portfolio consists of multi-antigen CAR T technology licensed from the University of Pittsburgh (SNAP-CAR), a cell therapy technology (CD38-GEAR-NK), and an in vitro diagnostic (CD38-Diagnostic) targeting CD38-related cancers, which the company is developing with VyGen-Bio and medical researchers at the Karolinska Institutet.
About ICMB Investcorp Credit Management BDC Inc.
Investcorp Credit Management BDC Inc is an externally managed, non-diversified closed-end management investment firm that has elected to be regulated as a business development company (BDC). Its investment objective is to maximize total return to stockholders in the form of current income and capital appreciation by investing in debt and related equity of privately held lower middle-market companies. The company principally invests in the debt of middle-market companies, which it defines as those companies that have an enterprise value.